Drugs for hypotension: disproportionate harms with etilefrine and heptaminol.

Abstract	The French Health Products Agency concluded that etilefrine and heptaminol have an unfavourable harm-benefit balance, and also placed restrictions on the use of midodrine.
Authors
Journal	Prescrire international (Prescrire Int) Vol. 24 Issue 162 Pg. 184 (Jul 2015) ISSN: 1167-7422 [Print] France
PMID	26240886 (Publication Type: Journal Article)
Chemical References	Heptaminol Etilefrine
Topics	Etilefrine (adverse effects) Heptaminol (adverse effects) Humans Hypotension (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!